MODERNA, INC.

MRNA
Real-time Estimate Cboe BZX - 12:25 2022-12-07 pm EST
176.75 USD +1.85%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:
- revenue from product sales (95.7%) ;
- revenues from grants (4%);
- revenues from collaboration agreements (0.3%).
At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development.
Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).

Number of employees : 2 700 people.
Sales per Business
20202021
mRNA Medicines803.40100%18 471.00100.3%
USD in Million
Sales per region
20202021
Europe--6 846.0037.2%
United States764.5395.2%6 177.0033.5%
Rest of World38.874.8%5 448.0029.6%
USD in Million
Managers
Name Title
Stphane Bancel Chief Executive Officer & Director
Stephen Hoge President
James M. Mock Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Paul Burton Chief Medical Officer
Paul L. Sagan Independent Non-Executive Director
Robert S. Langer Independent Non-Executive Director
Stephen A. Berenson Independent Non-Executive Director
Francois Nader Independent Non-Executive Director
Shareholders
Name Equities %
Baillie Gifford & Co. 45,280,023 11.6%
The Vanguard Group, Inc. 26,060,810 6.66%
Stphane Bancel 21,087,198 5.39%
Flagship Pioneering 17,281,016 4.42%
SSgA Funds Management, Inc. 14,506,066 3.71%
Robert Langer 11,510,060 2.94%
BlackRock Fund Advisors 7,021,768 1.79%
T. Rowe Price Associates, Inc. (Investment Management) 6,443,409 1.65%
Geode Capital Management LLC 6,247,811 1.60%
Thlme Partners LLP 6,004,406 1.53%
Company contact information
200 Square Technology
MA 02139 Cambridge, Massachusetts


Phone : +1 617 714 6500
Fax : +1 617 583 1998
web site : https://investors.modernatx.com/
Markets and indexes
- Nasdaq Global Select Market
- Nasdaq 100 / S&P 500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- Reuters Code :  MRNA.O
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
MODERNA, INC.-31.67%66 671
IQVIA HOLDINGS INC.-25.61%38 981
LONZA GROUP AG-36.87%37 974
ALNYLAM PHARMACEUTICALS, INC.33.39%27 022
SEAGEN INC.-23.73%21 892
CELLTRION, INC.-13.13%17 962
ICON PUBLIC LIMITED COMPANY-35.32%16 354
BIO-TECHNE CORPORATION-36.13%12 663
UNITED THERAPEUTICS CORPORATION28.01%12 607
QIAGEN N.V.-11.51%11 089
HANGZHOU TIGERMED CONSULTING CO., LTD.-27.94%10 921
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.-43.94%10 746
PHARMARON BEIJING CO., LTD.-29.49%10 617
BACHEM HOLDING AG-36.98%6 897
MEDPACE HOLDINGS, INC.-6.40%6 319
GENSCRIPT BIOTECH CORPORATION-39.57%5 670
IONIS PHARMACEUTICALS, INC.28.10%5 402
ROIVANT SCIENCES LTD.-37.20%4 592
AZENTA, INC.-41.65%4 395
JOINN LABORATORIES(CHINA)CO.,LTD.-26.53%4 326
ALKERMES PLC7.48%4 108
Brand Portfolio
MODERNA
MODERNA
MODERNA THERAPEUTICS
MODERNA THERAPEUTICS
More brands of Moderna, Inc.